Search Results - adam+montoya

1 Results Sort By:
Novel Inhibitors of Toll Like Receptor 4 for the Prevention and Treatment of Inflammatory Disorders
Unmet Need / Invention Novelty: TLR4 (Toll-like receptor 4) is the most upstream receptor in the pro-inflammatory cascade for endotoxin lipopolysaccharide (LPS). While normally downregulated gradually after full-term birth, high levels of TLR4 expression in infants born prematurely is associated with the development of NEC (necrotizing enterocolitis),...
Published: 7/5/2024   |   Inventor(s): David Hackam, Peng Lu, Chhinder Sodhi, Peter Wipf, Adam Montoya
Keywords(s):  
Category(s): Technology Classifications > Therapeutic Modalities > Small Molecules, Clinical and Disease Specializations > Inflammation > Necrotizing Enterocolitis, Clinical and Disease Specializations > Pediatrics
2017 - 2022 © Johns Hopkins Technology Ventures. All Rights Reserved. Powered by Inteum